Accessibility Menu
SpectraScience logo

SpectraScience(OTC) SCIE

This security has been delisted. This page is retained for historical reference.

SpectraScience last closing stock price
MetricPriceDate
Last closeUSD 0.002025-08-26
SpectraScience stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+0%USD 0.002025-08-14
1 month+0%USD 0.002025-07-11
3 month+0%USD 0.002025-05-21
Year to date+0%USD 0.002024-12-31
1 year+0%USD 0.002024-08-26
3 year+0%USD 0.002022-08-18
5 year-99%USD 0.002020-08-27
Since inception-100%USD 0.152004-08-25

SCIE News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

SCIE Financials

Key Financial Metrics (TTM)

Gross Margin

-3766.99%

Operating Margin

-47456.31%

Net Income Margin

-86737.86%

Return on Equity

50.86%

Return on Capital

N/A

Return on Assets

-322.21%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

-$196.00K

Operating Income

-$2.15M

EBITDA

-$3.87M

Operating Cash Flow

-$751.88K

Capital Expenditure

$0.00

Free Cash Flow

-$751.88K

Cash & ST Invst.

$27.88K

Total Debt

$7.92M

SpectraScience Performance Analysis

SpectraScience sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42016-12-31-100.0%
Q12017-03-31N/A
Q22017-06-30N/A
Q32017-09-30N/A
SpectraScience sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42016-12-31100.0%
Q12017-03-31N/A
Q22017-06-3011.1%
Q32017-09-3037.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name
Q3 2017YOY CHG

Revenue

$0.00

-100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/AMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

N/A

N/A

Employees

5

N/A

Net Income

-$1.55M

-99.2%

EBITDA

-$896.00K

-71.0%

Quarterly Fundamentals

Name
Q3 2017YOY CHG

Total Cash

$27.88K

+1346.9%

Total Debt

$7.92M

+9.0%

Accounts Receivable

$0.00

-100.0%

Inventory

$97.42K

-38.2%

Long Term Debt

$1.41M

N/A

Short Term Debt

$6.51M

-10.4%

Return on Assets

-3.22%

N/A

Return on Invested Capital

25.96%

N/A

Free Cash Flow

-$96.64K

+73.6%

Operating Cash Flow

-$96.64K

+73.6%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
BTTXBetter Therapeutics, Inc.
$0.00+0.00%
VIVEViveve Medical, Inc.
$0.00+0.00%
CALACalithera Biosciences, Inc.
$0.00+0.00%
MSGPMedSmart Group Inc.
$0.00+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
SOFISoFi Technologies
$15.25-0.09%
INTCIntel
$81.88-0.05%
NVDANvidia
$190.01-0.04%
TQQQProShares Trust - ProShares UltraPro Qqq
$57.75-0.06%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.